Skip to main content
. 2026 Jul 21;30(7):601–608. doi: 10.5005/jp-journals-10071-25242

Table 1.

Clinical and demographic risk factor distribution (N = 323)

Variable Total (N) MDRO-positive (n = 76) Prevalence (%)
Gender
Female 107 32 29.9
Male 216 44 20.3
Age
>60 years 169 48 28.4
<60 years 154 28 18.1
Length of stay
>15 days 60 28 46.6
10–15 days 56 13 23.2
5–10 days 146 30 20.5
≤5 days 61 5 8.2
History (past 3 months)
Antibiotic exposure
Prior antibiotic exposure 56 25 44.6
No prior antibiotic exposure 267 51 19.1
Hospitalization
Prior hospitalization 75 27 36.00
No prior hospitalization 248 49 19.7
Type of admission
Direct admission 232 57 24.5
Transfer from another hospital 91 19 20.8

%, Percentage; MDRO, multidrug-resistant organism; n, number of patients in a subgroup; N, total number of patients